Kratom-7 OH is emerging as a potent and addictive synthetic of kratom. Research suggests it presents similar risks as other ...

Molecular glues are revolutionizing cancer therapy by targeting undruggable proteins for degradation, enhancing precision ...

Research into Kisspeptin-10 has expanded well beyond its initial discovery as a metastasis suppressor fragment.

Arrowhead Pharmaceuticals, Inc. ( ARWR) TD Cowen Treatment Advancements in Obesity and Related Disorders Summit November 24, 2025 1:30 PM EST ...

B7-H4-targeted immunotherapies offer market opportunities in developing treatments for cancers with high B7-H4 expression, including ovarian, breast, and endometrial cancers. Utilizing diverse ...

The tools for advancing our understanding of basic biology have become increasingly capable of taking on large, ...

Discover the essential role of TGF-Beta 1 in cellular regulation, its signaling pathway, and how TGF-β1 antibodies are used ...

Two oral, and five poster presentations will showcase the company’s progress in developing allogenic cell therapy candidates for multiple ...

Discover six obesity deals made so far in 2025, with dealmaking activity in the field being largely dominated by big pharma companies.

Viagra and Cialis, and these drugs can be contraindicated for an estimated 16 million men living with diabetes CF602’s unique ...

AdipoR1 selectively recognizes adipokine ligands, differentially shaping T-cell immune outcomes. CTRP9 engages AdipoR1 to enhance T-cell glycolysis and immunity, whereas adiponectin suppresses them.

Researchers identified a key receptor that primes the formation of autoreactive B cells. Disrupting this pathway may be a potential therapy for lupus and beyond.